Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
01/23/2003 | US20030018195 Alpha-aminoacetic acid derivatives- alpha4beta7 receptor antagonists |
01/23/2003 | US20030018080 N-methoxymethyl-5,5-diphenylbarbituric acid |
01/23/2003 | US20030018057 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
01/23/2003 | CA2453451A1 Aminediols for the treatment of alzheimer's disease |
01/23/2003 | CA2453444A1 Diaminediols for the treatment of alzheimer's disease |
01/23/2003 | CA2453182A1 Crystalline thiazine oxazolidinones |
01/23/2003 | CA2452513A1 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
01/22/2003 | EP1277743A1 Oxa(thia)zolidine derivative and anti-inflammatory drug |
01/22/2003 | EP1277730A1 Neovascularization inhibitors |
01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
01/22/2003 | EP1276715A2 Method for oxidizing tertiary amines and aromatic heterocycles containing nitrogen |
01/21/2003 | US6509494 Distillation mixture of dicyclopentenyl esters |
01/21/2003 | US6509472 For use in enantioselective reduction of prochiral ketones to chiral secondary alcohols |
01/21/2003 | US6509363 P38 is a mitogen-activated protein kinase; pyrrole, oxazole, thiazole, and imidazole derivatives |
01/21/2003 | US6509354 3-arylphenyl sulfide derivative and insecticide and miticide |
01/17/2003 | WO2002006269A1 Cyclic amino acid derivatives |
01/17/2003 | CA2415964A1 Cyclic amino acid derivatives |
01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
01/16/2003 | WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
01/16/2003 | WO2003004479A1 4-aryl quinols and analogs thereof as therapeutic agents |
01/16/2003 | WO2003004458A1 New compounds |
01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
01/16/2003 | US20030013889 Process for the preparation of taxane derivatives |
01/16/2003 | US20030013888 Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid |
01/16/2003 | US20030013751 Viricides; enzyme inhibitors |
01/16/2003 | US20030013747 Novel substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents |
01/16/2003 | US20030013730 Preventing diarrhea |
01/16/2003 | US20030013725 Amino acid derivatives |
01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
01/16/2003 | CA2452592A1 4-aryl quinols and analogs thereof as therapeutic agents |
01/15/2003 | EP1274426A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
01/15/2003 | EP0862571B1 Herbicidal sulfonamides |
01/15/2003 | CN1391572A Oxazolidinones having sulfoximine functionality and their use as antimicrobial agents |
01/15/2003 | CN1391571A Heterocyclic compounds and their use as medicines |
01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
01/15/2003 | CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments |
01/15/2003 | CN1098844C Substituted biphenyloxazolines |
01/14/2003 | US6506908 From bicyclo(3.1.0)hexabe; decyclization; decarboxylation |
01/14/2003 | US6506905 Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid |
01/14/2003 | US6506797 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) α |
01/14/2003 | US6506781 Prevent formation of a hydrogen bond between the agonist and tyrosine or histidine, or tryptophan involved in receptor activation; and/or b) displace the tyrosine or histidine, or tryptophan involved in receptor activation from its agonist |
01/14/2003 | US6506757 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
01/14/2003 | US6506558 Deprotecting nucleoside, nucleotide or amino acid to form polypeptide or polynucleotide |
01/09/2003 | WO2003002540A1 Cyclic diamine compound having five-membered cyclic group |
01/09/2003 | WO2003002532A1 Cyclic diamine compounds having fused-ring groups |
01/09/2003 | WO2002020558A3 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
01/09/2003 | US20030009034 Transition metal mediated process |
01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
01/09/2003 | US20030008906 Administering benzothiazole compound for therapy, prophylaxis of disease |
01/08/2003 | EP1273572A1 Thiophene substituted piperazines useful in the treatment of benign prostatic hyperplasia |
01/08/2003 | EP1272537A2 Ether-amine based polymerization catalysts, compositions and processes using same |
01/08/2003 | EP1123284B1 Method for the preparation of citalopram |
01/08/2003 | CN1390211A Benzoic ester comprising ethoxyl acyl piperazine substituted oxazolidone compound |
01/08/2003 | CN1390210A Process for preparing oxazolines from tetrahydrofurans |
01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
01/08/2003 | CN1390122A Tissue factor antagonists and methods of use thereof |
01/08/2003 | CN1389458A P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
01/07/2003 | US6504046 Process for the preparation of amides |
01/07/2003 | US6503979 Production of diapers, tampons, sanitary towels and other hygiene articles |
01/07/2003 | US6503935 Imidazoles and related compounds as α1A agonists |
01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
01/03/2003 | WO2003000669A1 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds useful as insecticides and acaricides |
01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
01/03/2003 | WO2002083656A3 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
01/03/2003 | WO2002064577A3 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione |
01/02/2003 | US20030004212 Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists |
01/02/2003 | US20030004193 Immunomodulators; antiinflammatory agents |
01/02/2003 | US20030004160 Method for the preparation of oxazolidinones |
01/02/2003 | EP1268473A1 Oxazole derivatives and their uses as tyrosine kinase inhibitors |
01/02/2003 | EP1268461A1 Process for the preparation of citalopram |
01/02/2003 | EP1268096A1 Extrusion die |
01/02/2003 | EP1267867A1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists |
01/02/2003 | EP0821719B1 Liquid crystal compounds having a chiral fluorinated terminal portion |
01/02/2003 | EP0751939B9 Naphthylamides as central nervous system agents |
01/01/2003 | CN1388804A Amino acid-N-carboxy anhydrides having substitent at nitrogen |
01/01/2003 | CN1387849A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
01/01/2003 | CN1387848A Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
01/01/2003 | CN1097583C Process for preparing intermediates of florfenicol |
12/31/2002 | US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors |
12/26/2002 | US20020198245 Heterocyclic aromatic oxazole compounds and use thereof |
12/26/2002 | US20020198244 Heterocyclic aromatic oxazole compounds and use thereof |
12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
12/25/2002 | CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists |
12/25/2002 | CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides |
12/24/2002 | US6498276 Reacting amido acetic acid derivative with thionyl chloride to form oxazole compound which is reacted with halobenzoly compound |
12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
12/24/2002 | US6498256 Catalysts for asymmetric addition reactions, for example of hydrogen, to prochiral unsaturated organic compounds. |
12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
12/24/2002 | US6498179 Such as 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl)-2-(2-methyl-1 -imidazolyl)oxazole; insulin secertion promoting and blood sugar depressing effect; diabetes; low toxicity |
12/24/2002 | US6498178 Inhibitors of IMPDH enzyme |
12/24/2002 | US6498174 Agonists to peroxisome proliferator-activated receptors; modulating blood glucose and lipid levels; reducing dyslipidemia and hyperinsulinemia associated with impaired glucose tolerance or metabolic syndrome |
12/24/2002 | US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
12/19/2002 | WO2002100977A1 Organic electroluminescence device and luminance material |
12/19/2002 | WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections |
12/19/2002 | WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
12/19/2002 | WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
12/19/2002 | WO2002100842A1 Sulfonyloxazolamines and their use as 5-ht6 ligands |